PPARδ Agonists

PPARδ agonists are endurance- and fat-metabolism research compounds that act through the peroxisome proliferator-activated receptor delta pathway — driving fatty-acid oxidation and mitochondrial output rather than binding the androgen receptor. They are routinely shelved alongside SARMs in the research community, but they are a mechanistically distinct class. At Helixx this category is represented by Cardarine (GW-501516).